We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZLAB icon
1576
Zai Lab
ZLAB
$2.62B
– –
-1,585
Closed -$167K
ZNTL icon
1577
Zentalis Pharmaceuticals
ZNTL
$302M
– –
-1,030
Closed -$68K
QTTB icon
1578
Q32 Bio
QTTB
$464M
– –
-73
Closed -$10K
TECX
1579
Tectonic Therapeutic
TECX
$606M
– –
-83
Closed -$5K
KLRS
1580
Kalaris Therapeutics
KLRS
$96.8M
– –
-65
Closed -$37K
JOYY
1581
JOYY Inc
JOYY
$3.75B
– –
-6,512
Closed -$356K
ITCI
1582
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-1,860
Closed -$69K
SYRS
1583
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-142
Closed -$6K
RVNC
1584
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-1,645
Closed -$45K
PSTX
1585
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-1,425
Closed -$10K
CTLT
1586
DELISTED
CATALENT, INC.
CTLT
– –
-2,844
Closed -$378K
PETQ
1587
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-660
Closed -$16K
AAN
1588
DELISTED
The Aaron's Company Inc
AAN
– –
-16,283
Closed -$448K
EGRX
1589
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-300
Closed -$16K
GTHX
1590
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-965
Closed -$12K
DCPH
1591
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-1,330
Closed -$45K
FUSN
1592
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-980
Closed -$7K
SWAV
1593
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-45,658
Closed -$9.4M
MRNS
1594
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-835
Closed -$9K
EIGR
1595
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-26
Closed -$5K
NGM
1596
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-1,765
Closed -$37K
GMDA
1597
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
– –
-1,350
Closed -$5K
CBAY
1598
DELISTED
Cymabay Therapeutics
CBAY
– –
-1,580
Closed -$5K
BCEL
1599
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-690
Closed -$4K
KRTX
1600
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-675
Closed -$82K
62 63
64
65 66

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.